Pluripotent stem cell for modeling neurological diseases

被引：10
|
作者：
Yung, Jasmine Sum-Yee [1 ]
Tam, Paul Kwong-Hang [1 ,2 ]
Ngan, Elly Sau-Wai [1 ,2 ]
机构：
[1] Univ Hong Kong, Li Ka Shing Fac Med, Dept Surg Dev & Growth, Pokfulam, Hong Kong, Peoples R China
[2] Univ Hong Kong, Li Ka Shing Fac Med, Ctr Reprod Dev & Growth, Pokfulam, Hong Kong, Peoples R China
来源：
EXPERIMENTAL CELL RESEARCH | 2013年 / 319卷 / 02期
关键词：
Embryonic stem cells; Induced pluriopotent stem cells; Neurodevelopmental diseases and neurodegenerative diseases; MUSCULAR-ATROPHY PATIENT; MOTOR-NEURONS; RETT-SYNDROME; NEURAL DIFFERENTIATION; IPS CELLS; HUMAN ES; GENERATION; EXPRESSION; DERIVATION; SIGNALS;
D O I：
10.1016/j.yexcr.2012.11.007
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The availability of human pluriopotent stem cells, embryonic (ESC) and induced pluriopotent (iPSC) stem cells, not only can be a renewable source for investigating the early human development, etiology and progression of different diseases but also recapitulating the disease with the same genomic materials of the patient. In particular, specific neuronal subtypes generated from the patient ESC/iPSCs has become a source for studying disease mechanisms underlying different neurological disorders and allowed drug discovery. In this review, we summarize the recent advances in establishing patient ESC/iPSC to model various neurological diseases. We will also discuss the challenges and limitations of the current disease models and their potential future applications for untangling the unknowns in neurological disorders. (c) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码：177 / 184
页数：8
相关论文
共 50 条
  • [41] Microglia alterations in neurodegenerative diseases and their modeling with human induced pluripotent stem cell and other platforms
    Maria Sabogal-Guaqueta, Angelica
    Marmolejo-Garza, Alejandro
    de Padua, Vitor Passos
    Eggen, Bart
    Boddeke, Erik
    Dolga, Amalia M.
    PROGRESS IN NEUROBIOLOGY, 2020, 190
  • [42] Concise Review: Modeling Neurodegenerative Diseases with Human Pluripotent Stem Cell-Derived Microglia
    Haenseler, Walther
    Rajendran, Lawrence
    STEM CELLS, 2019, 37 (06) : 724 - 730
  • [43] Induced Pluripotent Stem Cell–Based Modeling of Single-Ventricle Congenital Heart Diseases
    Lauren E. Parker
    Leonie M. Kurzlechner
    Andrew P. Landstrom
    Current Cardiology Reports, 2023, 25 : 295 - 305
  • [44] Modeling human liver organ development and diseases with pluripotent stem cell-derived organoids
    Ouchi, Rie
    Koike, Hiroyuki
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2023, 11
  • [45] The Use of Pluripotent Stem Cell for Personalized Cell Therapies against Neurological Disorders
    Ha, Hye-Yeong
    Jang, Si-Hyong
    Jung, Ji-Won
    JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY, 2011,
  • [46] Induced pluripotent stem cells (iPSCs) and neurological disease modeling: progress and promises
    Marchetto, Maria C.
    Brennand, Kristen J.
    Boyer, Leah F.
    Gage, Fred H.
    HUMAN MOLECULAR GENETICS, 2011, 20 : R109 - R115
  • [47] Induced pluripotent stem cell modeling of malignant hematopoiesis
    Chao, Mark P.
    Majeti, Ravindra
    EXPERIMENTAL HEMATOLOGY, 2019, 71 : 68 - 76
  • [48] Pluripotent stem cell modeling of pulmonary arterial hypertension
    Qian, L.
    Karavenzas, K.
    Cheung, M.
    Stanley, E.
    Elliott, D. A.
    HUMAN GENE THERAPY, 2016, 27 (11) : A98 - A99
  • [49] Induced pluripotent stem cell for modeling Pompe disease
    Huang, Wenjun
    Zhang, Yanmin
    Zhou, Rui
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [50] Autologous haematopoietic stem cell transplantation for neurological diseases
    Burman, Joachim
    Tolf, Andreas
    Hagglund, Hans
    Askmark, Hakan
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2018, 89 (02): : 147 - 155
12345